Ertapenem sodium
- Level
- Commodity
- Parent
- 51284600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51284610This classification denotes a beta-lactam antibiotic with the molecular formula C22H23N3O7S.H+.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2T90KE67L0, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, disodium salt, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but more generally known as ertapenem sodium, which bears US NIH Compound Identifier 150611. European Medicines Agency schedules Ertapenem sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16424MIG. Most nations, for tariff and trade purposes, schedule ertapenem sodium under HS 29419000 and SITC 54139. Ertapenem sodium bears US NLM identifiers UMLS ID C1170745 and NCI Concept Code C61753. SMILES: As of Q4 2014, ERTAPENEM SODIUM remains US FDA's Preferred Term for this commodity.
Same parent
Under 51284600 · 13Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.